Allarity Therapeutics, Inc. Deferred Tax Assets, Goodwill and Intangible Assets
Allarity Therapeutics, Inc. (ALLR) had Deferred Tax Assets, Goodwill and Intangible Assets of $613.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $613.00K.
- 2024-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $719.00K.
- 2023-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $1.41M.
- 2022-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $1.16M.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2025-12-31 | $613.00K 10-K · filed 2026-03-30 |
| 2024-12-31 | $719.00K 10-K · filed 2026-03-30 |
| 2023-12-31 | $1.41M 10-K · filed 2024-03-08 |
| 2022-12-31 | $1.16M 10-K · filed 2024-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |